Back to Search Start Over

Protein S is protective in pulmonary fibrosis.

Authors :
Urawa M
Kobayashi T
D'Alessandro-Gabazza CN
Fujimoto H
Toda M
Roeen Z
Hinneh JA
Yasuma T
Takei Y
Taguchi O
Gabazza EC
Source :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2016 Aug; Vol. 14 (8), pp. 1588-99. Date of Electronic Publication: 2016 Jun 22.
Publication Year :
2016

Abstract

Unlabelled: Essentials Epithelial cell apoptosis is critical in the pathogenesis of idiopathic pulmonary fibrosis. Protein S, a circulating anticoagulant, inhibited apoptosis of lung epithelial cells. Overexpression of protein S in lung cells reduced bleomycin-induced pulmonary fibrosis. Intranasal therapy with exogenous protein S ameliorated bleomycin-induced pulmonary fibrosis.<br />Summary: Background Pulmonary fibrosis is the terminal stage of interstitial lung diseases, some of them being incurable and of unknown etiology. Apoptosis plays a critical role in lung fibrogenesis. Protein S is a plasma anticoagulant with potent antiapoptotic activity. The role of protein S in pulmonary fibrosis is unknown. Objectives To evaluate the clinical relevance of protein S and its protective role in pulmonary fibrosis. Methods and Results The circulating level of protein S was measured in patients with pulmonary fibrosis and controls by the use of enzyme immunoassays. Pulmonary fibrosis was induced with bleomycin in transgenic mice overexpressing human protein S and wild-type mice, and exogenous protein S or vehicle was administered to wild-type mice; fibrosis was then compared in both models. Patients with pulmonary fibrosis had reduced circulating levels of protein S as compared with controls. Inflammatory changes, the levels of profibrotic cytokines, fibrosis score, hydroxyproline content in the lungs and oxygen desaturation were significantly reduced in protein S-transgenic mice as compared with wild-type mice. Wild-type mice treated with exogenous protein S showed significant decreases in the levels of inflammatory and profibrotic markers and fibrosis in the lungs as compared with untreated control mice. After bleomycin infusion, mice overexpressing human protein S showed significantly low caspase-3 activity, enhanced expression of antiapoptotic molecules and enhanced Akt and Axl kinase phosphorylation as compared with wild-type counterparts. Protein S also inhibited apoptosis of alveolar epithelial cells in vitro. Conclusions These observations suggest clinical relevance and a protective role of protein S in pulmonary fibrosis.<br /> (© 2016 International Society on Thrombosis and Haemostasis.)

Details

Language :
English
ISSN :
1538-7836
Volume :
14
Issue :
8
Database :
MEDLINE
Journal :
Journal of thrombosis and haemostasis : JTH
Publication Type :
Academic Journal
Accession number :
27172994
Full Text :
https://doi.org/10.1111/jth.13362